ArticleAnnals of hematology2024

Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience.

Shuchao Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.